港股异动 | 金山软件涨逾4% 金山办公科创板IPO即将上会
格隆汇9月19日丨金山软件(3888.HK)现报19.18港元,涨4.24%,暂成交4586万港元,最新总市值263.3亿港元。昨日晚间,上交所官网显示,金山办公等3家公司更新上会稿,即将接受科创板上市委审议。据悉,因半年度财务数据更新而短暂放缓的科创板在审企业审核速度正逐渐恢复,科创板上市委将于9月27日召开第27次上市委审议会议,分别审议金山办公等3家公司的科创板首发上市申请。其中,金山办公无疑知名度最高,国产办公软件WPS Office和金山词霸均出自这家公司。此前广发证券发研报指,金山软件游戏波动短期影响投资情绪,办公和云前景相对乐观,WPS受益于国产化趋势,金山云受益于5G,维持“买入”评级。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.